Turkish Adaptation of the VascuQoL-6 Quality of Life Scale

NCT06979245 | Completed

• 1 other identifier: E-60116787-020-494225
• Study Type: observational
• Target: 37
• Locations: 1 country
• Sites: 2

Brief Summary

Study type: Observational study Primary objective: The aim of this study was to examine the validity and reliability of the Vascular Quality of Life Questionnaire-6 (VascuQoL-6) in Turkish in individuals diagnosed with Takayasu Arteritis or Vascular Behçet's disease. The main questions it aims to answer are: Can VascuQoL-6 measure disease-related quality of life validly and reliably? Does the scale show significant correlations with measures such as SF-36, EQ-5D-3L, BDCAF, BSAS and ITAS-2010? There is no comparison group. Participants will be asked to: Contribute to the translation process of the scale into Turkish, Complete all quality of life forms in the first assessment, Participate in the test-retest analysis by re-filling VascuQoL-6 one week later.

Conditions

Takayasu Arteritis; Behcet Disease; Quality of Life

Keywords

Takayasu arteritis; Behcet Disease; Turkish; Validity; Reliability; Quality of life

Outcome Measures

Primary Outcomes (1)

• Vascular Quality of Life Questionnaire-6

  VascuQoL aims to assess quality of life in peripheral arterial disease, regardless of disease severity (i.e. in intermittent claudication and critical limb ischemia). It consists of 6 items. Each item has a 7-point response scale (1: worst quality of life; 7: best quality of life).

  At enrollment and 1 week

Secondary Outcomes (5)

• Takayasu Arteritis: Kerr Criteria and Indian Takayasu's Clinical Activity Score (ITAS2010)

  At enrollment

• Short Form-36

  At enrollment

• EQ-5D-3L General Quality of Life Scale

  At enrollment

• Behcet's Disease Current Activity Form (BDCAF)

  At enrollment

• Behçet Syndrome Activity Scale

  At the enrollment

Study Arms (1)

Those diagnosed with Takayasu Arteritis or Vascular Behçet's disease

The study group was diagnosed with Takayasu Arteritis or Vascular Behçet's disease by a rheumatologist.

Eligibility Criteria

• Age: 18 Years - 65 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Probability Sample

Study Population

Those diagnosed with Takayasu Arteritis or Vascular Behçet's disease

You may qualify if:

• Being between the ages of 18-65
• Being willing to participate in the study
• Being diagnosed with Takayasu Arteritis or Vascular Behçet's disease by a rheumatologist

You may not qualify if:

• Having another disease that will affect their physical condition
• Having a cognitive disability that will prevent them from cooperating
• Being pregnant
• Having a neurological disease (hemiplegia, Parkinson's, multiple sclerosis, vertigo, epilepsy, etc.)
• Having undergone any surgery in the last year
• Having another simultaneous rheumatic disease

Sponsors & Collaborators

• Uşak University: lead
• Pamukkale University: collaborator

Study Sites (2)

Pamukkale University Rheumatology Clinic and Pamukkale University Faculty of Physiotherapy and Rehabilitation

Denizli, 20160, Turkey (Türkiye)

Location

Pamukkale University

Denizli, 20160, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Takayasu Arteritis; Behcet Syndrome

Condition Hierarchy (Ancestors)

Aortic Arch Syndromes; Aortic Diseases; Vascular Diseases; Cardiovascular Diseases; Arteritis; Vasculitis; Skin Diseases, Vascular; Skin Diseases; Skin and Connective Tissue Diseases; Mouth Diseases; Stomatognathic Diseases; Uveitis, Anterior; Panuveitis; Uveitis; Uveal Diseases; Eye Diseases; Hereditary Autoinflammatory Diseases; Genetic Diseases, Inborn; Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Skin Diseases, Genetic

Study Officials

• Bilge Basakcı Calık, Prof. Dr.

  Pamukkale University

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: OTHER
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principal Investigator

Study Record Dates

• First Submitted: May 11, 2025
• First Posted: May 18, 2025
• Study Start: March 1, 2025
• Primary Completion: August 10, 2025
• Study Completion: August 10, 2025
• Last Updated: August 22, 2025

Record last verified: 2025-08

Data Sharing

• IPD Sharing: Will not share

Locations

TU (2)